GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,110,000 | +263.9% | 232,172 | +163.1% | 0.01% | +50.0% |
| Q1 2020 | $305,000 | -41.9% | 88,243 | -2.8% | 0.01% | -38.5% |
| Q4 2019 | $525,000 | +51.3% | 90,748 | +25.0% | 0.01% | +62.5% |
| Q3 2019 | $347,000 | -22.5% | 72,595 | +19.1% | 0.01% | -27.3% |
| Q2 2019 | $448,000 | +2.1% | 60,948 | +13.4% | 0.01% | -15.4% |
| Q1 2019 | $439,000 | +57.3% | 53,749 | +31.6% | 0.01% | +18.2% |
| Q4 2018 | $279,000 | -42.7% | 40,844 | +13.9% | 0.01% | -26.7% |
| Q3 2018 | $487,000 | – | 35,846 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |